Bristol-Myers Squibb - 10% downside potential

When I see a stock go from 2.6 times sales to 6.4 times sales while revenues have fallen from $21 billion to $16 billion, you can tell that investors are hoping for something big coming down the road.

For now, I'll look for a trip down to the lower end of the rising regression channel.

Risk - $64 or $65. Target $53-$54.

Tim 4:25PM EST Feb 27, 2015